--- title: "Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition" type: "News" locale: "en" url: "https://longbridge.com/en/news/277213976.md" description: "Restart Life Sciences has acquired Holy Crap Foods Inc., gaining 100% ownership of the functional cereal brand and its assets, which adds over $1 million in annual revenue. This acquisition allows Restart Life to become a revenue-producing organization and control a manufacturing facility in Gibsons, B.C. The company plans to leverage Holy Crap’s established customer base for expansion in the health and wellness sector. The latest analyst rating for Stuhini Exploration (TSE:NOVA) is a Hold with a price target of C$0.21, reflecting concerns over financial performance despite some positive technical indicators." datetime: "2026-02-27T14:21:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277213976.md) - [en](https://longbridge.com/en/news/277213976.md) - [zh-HK](https://longbridge.com/zh-HK/news/277213976.md) --- # Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition ### Claim 50% Off TipRanks Premium - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Stuhini Exploration ( (TSE:NOVA) ) has provided an update. Restart Life Sciences has closed its acquisition of Holy Crap Foods Inc., securing 100% ownership of the functional cereal brand and its related assets, including intellectual property, inventory, and longstanding retail and distributor relationships. The deal immediately adds more than $1 million in annualized revenue and makes Restart Life a revenue-producing organization. The transaction also gives Restart Life control of Holy Crap’s turnkey manufacturing facility in Gibsons, B.C., providing scalable production capacity while limiting new capital spending. Management plans to maintain existing operations, collaborate with Holy Crap’s team, and use the brand’s established customer base and in-house production as a platform to expand distribution, improve efficiencies, and pursue new product development in the health and wellness sector. The most recent analyst rating on (TSE:NOVA) stock is a Hold with a C$0.21 price target. To see the full list of analyst forecasts on Stuhini Exploration stock, see the TSE:NOVA Stock Forecast page. **Spark’s Take on TSE:NOVA Stock** According to Spark, TipRanks’ AI Analyst, TSE:NOVA is a Neutral. The score is held down primarily by weak financial performance (no revenue, persistent losses, and ongoing cash burn), with valuation also constrained by negative earnings (negative P/E). These negatives are partially offset by favorable technicals (price above key moving averages with positive momentum) and a low-leverage balance sheet with no debt. To see Spark’s full report on TSE:NOVA stock, click here. **More about Stuhini Exploration** Restart Life Sciences Corp. is a health and wellness company that is transitioning into a revenue-generating business through branded consumer products. Its focus now includes natural functional foods, with a newly acquired portfolio centred on the Holy Crap cereal brand, supported by in-house manufacturing and established retail and direct-to-consumer channels. **Average Trading Volume:** 89,403 **Technical Sentiment Signal:** Hold **Current Market Cap:** C$9.74M See more data about NOVA stock on TipRanks’ Stock Analysis page. ### Related Stocks - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [SAVU.US](https://longbridge.com/en/quote/SAVU.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [RSLS.US](https://longbridge.com/en/quote/RSLS.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [ATNFW.US](https://longbridge.com/en/quote/ATNFW.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [HEAL.US](https://longbridge.com/en/quote/HEAL.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [ATNF.US](https://longbridge.com/en/quote/ATNF.US.md) ## Related News & Research - [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md) - [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md) - [IT Sector Accounts for Nearly One Third of U.S. Securities Litigation Risk in 1H 2026](https://longbridge.com/en/news/294507902.md) - [Biotech experts want FDA drug reviews based on science, not politics](https://longbridge.com/en/news/293453841.md) - [3 healthcare ETFs to own in a choppy stock market](https://longbridge.com/en/news/291834343.md)